Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mechanical occlusion of the lacrimal drainage system is a therapeutic intervention designed to manage aqueous-deficient dry eye disease by physically blocking the tear exit pathways (StatPearls, 2023). This procedure typically involves the insertion of punctal plugs—small devices made of collagen or silicone—into the lacrimal puncta or canaliculi to inhibit the drainage of tears into the nasolacrimal duct (American Academy of Ophthalmology, 2022). By increasing the volume and retention time of the tear film on the ocular surface, mechanical occlusion helps alleviate symptoms of dryness, irritation, and corneal damage. It is not a molecular target such as a receptor or enzyme, but rather a mechanical method to alter ocular fluid dynamics. While generally safe, the procedure can lead to complications such as epiphora (overflow of tears), localized infection (canaliculitis), or device-related irritation (Mayo Clinic, 2023).
Mechanical obstruction of the lacrimal puncta or canaliculi to inhibit the drainage of natural and artificial tears, thereby increasing tear volume and residence time on the ocular surface.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mechanical occlusion of lacrimal drainage system.